DBV Technologies Ownership
| DBVT Stock | USD 9.46 0.32 3.27% |
Shares in Circulation | First Issued 2020-03-31 | Previous Quarter 19 M | Current Value 21 M | Avarage Shares Outstanding 15.3 M | Quarterly Volatility 4.1 M |
DBV Stock Ownership Analysis
The company recorded a loss per share of 5.75. DBV Technologies had not issued any dividends in recent years. The entity had 1:2 split on the 7th of June 2024. DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France. DBV Technologies operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people. To learn more about DBV Technologies call Daniel Tass at 33 1 55 42 78 78 or check out https://www.dbv-technologies.com.DBV Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as DBV Technologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading DBV Technologies backward and forwards among themselves. DBV Technologies' institutional investor refers to the entity that pools money to purchase DBV Technologies' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jpmorgan Chase & Co | 2025-03-31 | 120 | Northwestern Mutual Wealth Management Co | 2025-03-31 | 111 | Banque Transatlantique | 2025-03-31 | 92.0 | Curio Wealth, Llc | 2025-03-31 | 12.0 | Advisor Group Holdings, Inc. | 2025-03-31 | 11.0 | Vivo Capital, Llc | 2025-03-31 | 0.0 | Janney Montgomery Scott Llc | 2024-12-31 | 0.0 | Citadel Advisors Llc | 2024-12-31 | 0.0 | Millennium Management Llc | 2024-12-31 | 0.0 | Baker Bros Advisors Lp | 2025-03-31 | 1.5 M | Yiheng Capital Llc | 2025-03-31 | 656.3 K |
DBV Technologies Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DBV Technologies insiders, such as employees or executives, is commonly permitted as long as it does not rely on DBV Technologies' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases DBV Technologies insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
DBV Technologies Outstanding Bonds
DBV Technologies issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. DBV Technologies uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most DBV bonds can be classified according to their maturity, which is the date when DBV Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
DBV Technologies Corporate Filings
8K | 25th of June 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 24th of June 2025 Other Reports | ViewVerify | |
| 29th of May 2025 Other Reports | ViewVerify | |
F4 | 27th of May 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for DBV Stock Analysis
When running DBV Technologies' price analysis, check to measure DBV Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DBV Technologies is operating at the current time. Most of DBV Technologies' value examination focuses on studying past and present price action to predict the probability of DBV Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DBV Technologies' price. Additionally, you may evaluate how the addition of DBV Technologies to your portfolios can decrease your overall portfolio volatility.